October 30, 2019
VIA EDGAR Securities and Exchange Commission
Division of Corporation Finance 100 F Street, N.E.
Washington, D.C. 20549
Re: Hoverink Biotechnologies, Inc.Registration Statement on Form S-1 Filed on DEC 20 2018
Ladies and Gentlemen: Hoverink Biotechnologies, Inc. (the “Company”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) consent to the immediate request to withdraw Form S-1 which was filed on 12/20/2018. We hereby request to to withdraw the registration statement Form (S-1) together with all exhibits and amendments to each registration statement thereto (collectively, the “Registration Statement”).
Should you have any questions, please contact Debbie Carter at info@hoverink.net.
Hoverink Biotechnologies, Inc. | ||
By: | /s/ Debbie Carter | |
Debbie Carter | ||
Chief Executive Officer |